Xintela AB (publ) (STO:XINT)
0.252
-0.008 (-3.08%)
At close: Mar 9, 2026
Xintela AB Revenue
In the year 2025, Xintela AB had annual revenue of 2.28M SEK, down -45.86%. Xintela AB had revenue of 415.00K in the quarter ending December 31, 2025, a decrease of -61.93%.
Revenue
2.28M
Revenue Growth
-45.86%
P/S Ratio
98.13
Revenue / Employee
175.54K
Employees
13
Market Cap
223.93M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Intervacc AB | 20.09M |
| Sprint Bioscience AB | 167.17M |
| Mendus AB | -1.44M |
| Lipum AB | 1.93M |
| Magle Chemoswed Holding AB | 300.49M |
| Bio-Works Technologies AB | 63.11M |
| Elicera Therapeutics AB | 10.86M |
| Simris Group AB (PUBL) | 1.62M |